Literature DB >> 9240429

Eotaxin expression and eosinophilic inflammation in asthma.

S Mattoli1, M A Stacey, G Sun, A Bellini, M Marini.   

Abstract

Asthma is a chronic inflammatory disease of the airways characterized by a marked infiltration of eosinophils in the bronchial mucosa, and the mechanisms that cause the selective recruitment of these cells are areas of active investigation. In this study, we found increased expression of the eosinophil chemoattractant eotaxin in bronchial mucosa of asthmatic patients. The increase in number of cells expressing eotaxin mRNA correlated with the number of eosinophils in the bronchial tissue and with two major clinical and functional indices of disease severity, suggesting that eotaxin is involved in the recruitment of eosinophils and in eosinophil-induced tissue damage in asthma. Cell sources of eotaxin were bronchial epithelial cells, T lymphocytes, macrophages and eosinophils themselves. The use of drugs that interfere with eotaxin synthesis and function may represent a more specific approach in asthma treatment.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9240429     DOI: 10.1006/bbrc.1997.6958

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  21 in total

Review 1.  Cytokines in asthma.

Authors:  K F Chung; P J Barnes
Journal:  Thorax       Date:  1999-09       Impact factor: 9.139

Review 2.  Eotaxin and asthma: some answers, more questions.

Authors:  C J Corrigan
Journal:  Clin Exp Immunol       Date:  1999-04       Impact factor: 4.330

Review 3.  Chemokines in allergic lung inflammation.

Authors:  Clare Lloyd
Journal:  Immunology       Date:  2002-02       Impact factor: 7.397

4.  Eotaxin expression in Sephadex-induced lung injury in rats.

Authors:  R F Guo; P A Ward; J A Jordan; M Huber-Lang; R L Warner; M M Shi
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

5.  Temporal production of CCL28 corresponds to eosinophil accumulation and airway hyperreactivity in allergic airway inflammation.

Authors:  Alison E John; Molly S Thomas; Aaron A Berlin; Nicholas W Lukacs
Journal:  Am J Pathol       Date:  2005-02       Impact factor: 4.307

6.  Induction of eotaxin expression and release from human airway smooth muscle cells by IL-1beta and TNFalpha: effects of IL-10 and corticosteroids.

Authors:  K F Chung; H J Patel; E J Fadlon; J Rousell; E B Haddad; P J Jose; J Mitchell; M Belvisi
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

7.  Kinetics of eotaxin expression and its relationship to eosinophil accumulation and activation in bronchial biopsies and bronchoalveolar lavage (BAL) of asthmatic patients after allergen inhalation.

Authors:  J R Brown; J Kleimberg; M Marini; G Sun; A Bellini; S Mattoli
Journal:  Clin Exp Immunol       Date:  1998-11       Impact factor: 4.330

8.  Human eotaxin induces eosinophil extravasation through rat mesenteric venules: role of alpha4 integrins and vascular cell adhesion molecule-1.

Authors:  K Nagai; S Larkin; A Hartnell; K Larbi; M Razi Aghakhani; C Windley; D Davies; R R Lobb; T J Williams; S Nourshargh
Journal:  Immunology       Date:  1999-02       Impact factor: 7.397

9.  Failure of sputum eosinophilia after eotaxin inhalation in asthma.

Authors:  D Bumbacea; J Scheerens; B S Mann; R G Stirling; K F Chung
Journal:  Thorax       Date:  2004-05       Impact factor: 9.139

10.  Highly up-regulated CXCR3 expression on eosinophils in mice infected with Schistosoma japonicum.

Authors:  He Li; Hu Chunsong; Cai Guobin; Zhang Qiuping; Li Qun; Zhang Xiaolian; Huang Baojun; Zhang Linjie; Liu Junyan; Jiang Mingshen; Tan Jinquan
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.